Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lupron for Ovarian Protection During Cyclophosphamide Therapy
NCT01257802Phase 3Terminated
- Start
- May 2011
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in primary ovarian insufficiency (POI). Started May 2011; status: terminated.
02
Drugs
leuprolide
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT01257802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257802.